GeneDx Holdings Corp. (WGS) Cash From Financing

Annual CFF:

$44.16M-$142.08M(-76.29%)
December 31, 2024

Summary

  • As of today, WGS annual cash from financing is $44.16 million, with the most recent change of -$142.08 million (-76.29%) on December 31, 2024.
  • During the last 3 years, WGS annual cash from financing has fallen by -$449.57 million (-91.06%).
  • WGS annual cash from financing is now -91.06% below its all-time high of $493.73 million, reached on December 31, 2021.

Performance

WGS Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherWGScash flow metrics

Quarterly CFF:

$10.77M+$10.42M(+3012.14%)
September 30, 2025

Summary

  • As of today, WGS quarterly cash from financing is $10.77 million, with the most recent change of +$10.42 million (+3012.14%) on September 30, 2025.
  • Over the past year, WGS quarterly cash from financing has dropped by -$3.20 million (-22.91%).
  • WGS quarterly cash from financing is now -97.84% below its all-time high of $499.40 million, reached on September 1, 2021.

Performance

WGS Quarterly Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherWGScash flow metrics

TTM CFF:

$55.85M-$3.20M(-5.42%)
September 30, 2025

Summary

  • As of today, WGS TTM cash from financing is $55.85 million, with the most recent change of -$3.20 million (-5.42%) on September 30, 2025.
  • Over the past year, WGS TTM cash from financing has dropped by -$4.39 million (-7.28%).
  • WGS TTM cash from financing is now -91.98% below its all-time high of $696.81 million, reached on June 1, 2022.

Performance

WGS TTM Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherWGScash flow metrics

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

WGS Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-76.3%-22.9%-7.3%
3Y3 Years-91.1%+1764.3%-71.6%
5Y5 Years-70.2%--

WGS Cash From Financing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-91.1%at low-91.9%+1282.0%-83.1%+26.5%
5Y5-Year-91.1%at low-97.8%+554.5%-92.0%+1150.4%
All-TimeAll-Time-91.1%at low-97.8%+554.5%-92.0%+1150.4%

WGS Cash From Financing History

DateAnnualQuarterlyTTM
Sep 2025
-
$10.77M(+3012.1%)
$55.85M(-5.4%)
Jun 2025
-
$346.00K(-97.5%)
$59.05M(+1.3%)
Mar 2025
-
$13.72M(-55.8%)
$58.32M(+32.1%)
Dec 2024
$44.16M(-76.3%)
$31.02M(+122.1%)
$44.16M(-26.7%)
Sep 2024
-
$13.97M(+3672.4%)
$60.24M(+32.8%)
Jun 2024
-
-$391.00K(+10.7%)
$45.36M(-14.6%)
Mar 2024
-
-$438.00K(-100.9%)
$53.14M(-71.5%)
Dec 2023
$186.24M(-5.6%)
$47.10M(+5270.5%)
$186.24M(+33.8%)
Sep 2023
-
-$911.00K(-112.3%)
$139.20M(-0.2%)
Jun 2023
-
$7.39M(-94.4%)
$139.46M(-57.8%)
Mar 2023
-
$132.66M(>+9900.0%)
$330.13M(+67.3%)
DateAnnualQuarterlyTTM
Dec 2022
$197.31M(-60.0%)
$65.00K(+110.0%)
$197.31M(+0.3%)
Sep 2022
-
-$647.00K(-100.3%)
$196.76M(-71.8%)
Jun 2022
-
$198.06M(>+9900.0%)
$696.81M(+40.4%)
Mar 2022
-
-$160.00K(+67.5%)
$496.38M(+0.4%)
Dec 2021
$493.73M(+282.6%)
-
-
Dec 2021
-
-$492.00K(-100.1%)
$494.27M(-1.9%)
Sep 2021
-
$499.40M(>+9900.0%)
$503.87M(>+9900.0%)
Jun 2021
-
-$2.37M(-4.0%)
$4.47M(-34.7%)
Mar 2021
-
-$2.28M(-125.0%)
$6.84M(-25.0%)
Dec 2020
$129.06M(-12.8%)
$9.11M
$9.11M
Dec 2019
$148.01M
-
-

FAQ

  • What is GeneDx Holdings Corp. annual cash from financing?
  • What is the all-time high annual cash from financing for GeneDx Holdings Corp.?
  • What is GeneDx Holdings Corp. annual cash from financing year-on-year change?
  • What is GeneDx Holdings Corp. quarterly cash from financing?
  • What is the all-time high quarterly cash from financing for GeneDx Holdings Corp.?
  • What is GeneDx Holdings Corp. quarterly cash from financing year-on-year change?
  • What is GeneDx Holdings Corp. TTM cash from financing?
  • What is the all-time high TTM cash from financing for GeneDx Holdings Corp.?
  • What is GeneDx Holdings Corp. TTM cash from financing year-on-year change?

What is GeneDx Holdings Corp. annual cash from financing?

The current annual cash from financing of WGS is $44.16M

What is the all-time high annual cash from financing for GeneDx Holdings Corp.?

GeneDx Holdings Corp. all-time high annual cash from financing is $493.73M

What is GeneDx Holdings Corp. annual cash from financing year-on-year change?

Over the past year, WGS annual cash from financing has changed by -$142.08M (-76.29%)

What is GeneDx Holdings Corp. quarterly cash from financing?

The current quarterly cash from financing of WGS is $10.77M

What is the all-time high quarterly cash from financing for GeneDx Holdings Corp.?

GeneDx Holdings Corp. all-time high quarterly cash from financing is $499.40M

What is GeneDx Holdings Corp. quarterly cash from financing year-on-year change?

Over the past year, WGS quarterly cash from financing has changed by -$3.20M (-22.91%)

What is GeneDx Holdings Corp. TTM cash from financing?

The current TTM cash from financing of WGS is $55.85M

What is the all-time high TTM cash from financing for GeneDx Holdings Corp.?

GeneDx Holdings Corp. all-time high TTM cash from financing is $696.81M

What is GeneDx Holdings Corp. TTM cash from financing year-on-year change?

Over the past year, WGS TTM cash from financing has changed by -$4.39M (-7.28%)
On this page